Infliximab for rheumatoid arthritis.

about

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.

P2860

Q39510138-78BBF2DE-AEDD-411B-B0BD-612D982BB083

P2860

Infliximab for rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q52856626

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Infliximab for rheumatoid arthritis.

@en

Infliximab for rheumatoid arthritis.

@en-gb

Infliximab for rheumatoid arthritis.

@nl

type

Item

label

Infliximab for rheumatoid arthritis.

@en

Infliximab for rheumatoid arthritis.

@en-gb

Infliximab for rheumatoid arthritis.

@nl

prefLabel

Infliximab for rheumatoid arthritis.

@en

Infliximab for rheumatoid arthritis.

@en-gb

Infliximab for rheumatoid arthritis.

@nl

P1476

Infliximab for rheumatoid arthritis.

@en

P2093

Benazir Saleem

http://www.w3.org/2001/XMLSchema#string

Sarah Mackie

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

P304

193-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2.2.193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Emery

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477071

http://www.w3.org/2001/XMLSchema#string

Infliximab for rheumatoid arthritis.

about

P2860

P2860

Infliximab for rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698